ABOUT THIS EPISODE
Host: Jennifer Caudle, DO
Guest: Francesca Taraballi, PhD
Guest: John J. Russell, MD
Guest: Francesca Taraballi, PhD
Guest: John J. Russell, MD
As mRNA therapeutics continue to emerge, what do our patients know about them? Joining Dr. Jennifer Caudle to explore knowledge gaps and discuss tactics to educate patients are Drs. John Russell and Francesca Taraballi.
English
United States
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Innovations In Medicine.
OTHER EPISODES IN THIS PODCAST
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: George Grossberg, MD
Guest: Angela Sanford, MD, CMD
Nearly half of patients living with dementia due to Alzheimer’s disease will experience agitation during the course of illness.1 In June 2025, expert panel recommendations on ident…
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Musaddiq Khan
Clinical data continues to emerge on mRNA therapeutics and their applications. What do we need to know about this data, and are there any barriers to the broader application of these therapeutics? Dr. Charles Turck is joined by M…
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Piotr Kowalski, PhD
mRNA technology may have a potential role in several areas of gene editing. But are there any barriers to its application in clinical practice? Dr. Piotr Kowalski from the University College Cork explores mRNA technology in…
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Ahmed Zayed Obeidat, MD, PhD
Multiple sclerosis (MS) is a disabling disease that has challenged clinicians for decades. But developments in our understanding of the Epstein-Barr virus and emerging mRNA therapeutics may help us determine the ro…
Disclaimer: The podcast and artwork embedded on this page are from ReachMD, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
